Literature DB >> 20696799

Neuroleptic malignant syndrome: a neuroimmunologic hypothesis.

Rebecca E Anglin1, Patricia I Rosebush, Michael F Mazurek.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20696799      PMCID： PMC3001529          DOI： 10.1503/cmaj.091442

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  29 in total

Review 1.  Heat stroke.

Authors:  Abderrezak Bouchama; James P Knochel
Journal:  N Engl J Med       Date:  2002-06-20       Impact factor: 91.245

2.  Catatonia and the neuroleptic malignant syndrome--a single entity?

Authors:  D A White
Journal:  Br J Psychiatry       Date:  1992-10       Impact factor: 9.319

3.  Neuroleptic malignant syndrome and the acute phase response.

Authors:  Patricia I Rosebush; Rebecca E Anglin; Carl Richards; Michael F Mazurek
Journal:  J Clin Psychopharmacol       Date:  2008-08       Impact factor: 3.153

Review 4.  Electroconvulsive treatment of neuroleptic malignant syndrome: a review and report of cases.

Authors:  J N Trollor; P S Sachdev
Journal:  Aust N Z J Psychiatry       Date:  1999-10       Impact factor: 5.744

Review 5.  Exposure to acute stress induces brain interleukin-1beta protein in the rat.

Authors:  K T Nguyen; T Deak; S M Owens; T Kohno; M Fleshner; L R Watkins; S F Maier
Journal:  J Neurosci       Date:  1998-03-15       Impact factor: 6.167

6.  Serum iron and neuroleptic malignant syndrome.

Authors:  P I Rosebush; M F Mazurek
Journal:  Lancet       Date:  1991-07-20       Impact factor: 79.321

7.  The combined effect of viruses and drugs in drug-induced diseases.

Authors:  M Levy
Journal:  Med Hypotheses       Date:  1984-07       Impact factor: 1.538

8.  Evidence that brief stress may induce the acute phase response in rats.

Authors:  T Deak; J L Meriwether; M Fleshner; R L Spencer; A Abouhamze; L L Moldawer; R E Grahn; L R Watkins; S F Maier
Journal:  Am J Physiol       Date:  1997-12

9.  Neuroleptic malignant syndrome: a pathogenetic role for dopamine receptor blockade?

Authors:  V W Henderson; G F Wooten
Journal:  Neurology       Date:  1981-02       Impact factor: 9.910

10.  Effect of iron chelators on dopamine D2 receptors.

Authors:  D Ben-Shachar; J P Finberg; M B Youdim
Journal:  J Neurochem       Date:  1985-10       Impact factor: 5.372
View more
  9 in total

1.  Index of suspicion. Case 2: Fever and Irritability in a 15-year-old Boy With Autism.

Authors:  Christine Westfall; Charles J Mullett; Linda S Nield
Journal:  Pediatr Rev       Date:  2015-07

2.  Combination of Steven-Johnson syndrome and neuroleptic malignant syndrome following carbamazepine therapy: a rare occurrence.

Authors:  Bhawna Sharma; Raghavendra Bakki Sannegowda; Pankaj Gandhi; Parul Dubey; Ashok Panagariya
Journal:  BMJ Case Rep       Date:  2013-06-11

3.  Neuroleptic Malignant Syndrome Associated with Refractory Acute Disseminated Encephalomyelitis.

Authors:  Silvia R Delgado; Leticia Tornes; Janice Maldonado; Jeffrey Hernandez; Yesica Campos; Kottil Rammohan
Journal:  Case Rep Neurol       Date:  2016-04-28

Review 4.  The pathophysiological basis and consequences of fever.

Authors:  Edward James Walter; Sameer Hanna-Jumma; Mike Carraretto; Lui Forni
Journal:  Crit Care       Date:  2016-07-14       Impact factor: 9.097

Review 5.  Catatonia and the immune system: a review.

Authors:  Jonathan P Rogers; Thomas A Pollak; Graham Blackman; Anthony S David
Journal:  Lancet Psychiatry       Date:  2019-06-10       Impact factor: 77.056

6.  Neuroleptic malignant syndrome associated with COVID-19 vaccination.

Authors:  Takahiko Nagamine
Journal:  CJEM       Date:  2021-12-17       Impact factor: 2.929

Review 7.  Drug-Induced Hyperthermia Review.

Authors:  Michael Horseman; Ladan Panahi; George Udeani; Andrew S Tenpas; Rene Verduzco; Pooja H Patel; Daniela Z Bazan; Andrea Mora; Nephy Samuel; Anne-Cecile Mingle; Lisa R Leon; Joseph Varon; Salim Surani
Journal:  Cureus       Date:  2022-07-26

Review 8.  Neuroleptic Malignant Syndrome: A Review from a Clinically Oriented Perspective.

Authors:  Lurdes Tse; Alasdair M Barr; Vanessa Scarapicchia; Fidel Vila-Rodriguez
Journal:  Curr Neuropharmacol       Date:  2015       Impact factor: 7.363

9.  Neuroleptic malignant syndrome following reintroduction of an antipsychotic after overdose.

Authors:  Théo Korchia; Graham Blackman; Michel Cermolacce; Raphaëlle Richieri
Journal:  BMJ Case Rep       Date:  2018-08-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.